<DOC>
	<DOCNO>NCT01479218</DOCNO>
	<brief_summary>The objective study investigate safety , efficacy clinical utility Occlutech PDA device closure patent ductus arteriosus type .</brief_summary>
	<brief_title>Safety Effectiveness Study With New PDA Occluder Closure Patent Ductus Arteriosus</brief_title>
	<detailed_description />
	<mesh_term>Ductus Arteriosus , Patent</mesh_term>
	<criteria>1 . Patients demonstrate patent ductus arteriosus 2 . Female male 3 . Belonging ethnic group 4 . Age &gt; 6 month 70 year 5 . Body weight &gt; 6 kg &lt; 120 kg 1 . Associated congenital cardiac anomaly , 2 . Body weight &lt; 6 Kilograms General exclusion criterion presence know coagulation disorder thrombus position allocate implantation vein thrombosis blood vessel choose introduce system active infection Nitinol intolerance ( nickel titanium ) contrast medium intolerance patient vascular system small admit require sheath patient pulmonary hypertension pulmonaryvascular resistance &gt; 8 Woods Units lung / systemic resistance ( PR/SR ) &gt; 0.4 .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>